$69.99 0.00 (0%)
11/24/2008 4:00 PM

ImClone Systems, Inc. (NASDAQ:IMCL.DL)

CAPS Rating: No stars

A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.

Recs

0
Player Avatar biopharminvestor (< 20) Submitted: 9/16/2008 9:50:11 PM : Underperform Start Price: $60.30 IMCL.DL Score: -45.03

Take over rumors....company has over-hyped itself in other situations. I suspect they're doing so now. Fool me once, shame on you; fool me twice, shame on me.

Report this Post Add Comment

Featured Broker Partners


Advertisement